IPCA Labs: Eyes on FDA officials visit

The US FDA could re-inspect the three facilities of Ipca Laboratories that are under the regulator’s import alert, in September. In the first half of the next fiscal there could be an inspection but it is difficult to say when the FDA officials will come for an inspection, said a Cogencis report quoting the investor conference call meet. Investors will closely monitor the development, as the resolution at these units would lead to a significant increase in product approvals.

Published on February 08, 2018
TOPICS
pharmaceutical
Ipca Laboratories Ltd

Previous Story Shares fragile; US yields creep up after budget deal

Next Story Wall Street fades in choppy trade after week's wild start

MORE FROM BUSINESSLINE


 Getting recommendations just for you...
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.